The Counterfactual Question: What Difference Did We Actually Make?

At the inaugural gathering of advanced impact management practitioners, we tackled this question head-on. As a group, we explored some of the challenges we face when trying to map out a theoretical scenario where we choose not to act, or what we call: the counterfactual.

MedAccess to scope opportunities to make mental health treatments more accessible and affordable

EIB signs a Guarantee Agreement with MedAccess to boost access to essential medical supplies in Africa

New interview series explores the science, art and impact of market shaping

The crucial role of diagnostics: Insights from Sickle Cell Disease 

By Priyanka Nankani, Health Investment Analyst, MedAccess

MedAccess working capital facility to help Hemex boost access to sickle cell diagnosis

Millions more people accessing health products supported by MedAccess’ guarantees

MedAccess partners with Gavi to develop advance financing mechanism for African vaccine manufacturing

Professor Helen Rees recognised for outstanding contribution to global health

Overcoming barriers to African vaccine manufacturing

By Guy Pickles, Head of Vaccines, MedAccess

What’s the latest on global access to medicines?

by Ramon Brown, Impact Analyst, MedAccess

The role of forecasting in market shaping: Hema Srinivasan on Forecasting Impact podcast

By MedAccess

MedAccess joins G7 DFIs initiative to prepare for future pandemics

by MedAccess

Combatting antimicrobial resistance with stewardship

by Takhona Hlatshwako, Impact Intern

MedAccess welcomes Cyrus Ardalan to its Board of Directors

by MedAccess

UK improves access to life-saving malaria drugs

From: Foreign, Commonwealth & Development Office and The Rt Hon Andrew Mitchell MP

First published here

Do you speak market shaping? Reflections from the first Global Health Market Shaping conference

by Tristana Perez, Development Impact Executive

Alison Evans and Anil Soni join MedAccess Board

by MedAccess

Keeping impact at the heart of MedAccess’ investment decisions

by MedAccess

How do advance market commitments and volume guarantees shape healthcare markets?

by Michelle Teo, Chief Investment Officer, MedAccess

Antony Ross OBE appointed Chair of MedAccess Investment Committee

by MedAccess

MedAccess becomes founding partner of G7 initiative for impact investing in health

by MedAccess

Non-communicable diseases: Tailoring our approach to innovative finance

by Mayank Anand, Vice President, Health Markets

MedAccess guarantees help medical innovations reach 530 million people in five years

by MedAccess

Building better boardrooms with Violet Mordichai and TheBoardroom Africa

by Willem Verhoofstad, MedAccess Board member

Five key lessons from our first five years

by MedAccess

Professor Helen Rees appointed MedAccess Board Chair

by MedAccess

MedAccess expects to deploy more than $150 million to support Global Fund’s fight against HIV, TB and malaria

by MedAccess

2021 Annual Review: Accelerating impact and preparing for the future

by MedAccess

Violet Mordichai joins MedAccess on board apprenticeship programme

by MedAccess

MedAccess welcomes Vicky Johnson as new Chief Financial Officer

by MedAccess

Promising progress but more to do for adolescent girls’ health

by Tristana Perez, Development Impact Executive

MedAccess’ life-changing impact highlighted in first Annual Report

by MedAccess

Hema Srinivasan appointed Chief Access Officer

by MedAccess

Fresh support from CDC Group at Global Fund Replenishment

by MedAccess

The Counterfactual Question: What Difference Did We Actually Make?

MedAccess to scope opportunities to make mental health treatments more accessible and affordable

EIB signs a Guarantee Agreement with MedAccess to boost access to essential medical supplies in Africa

New interview series explores the science, art and impact of market shaping

The crucial role of diagnostics: Insights from Sickle Cell Disease

MedAccess working capital facility to help Hemex boost access to sickle cell diagnosis

Millions more people accessing health products supported by MedAccess’ guarantees

MedAccess partners with Gavi to develop advance financing mechanism for African vaccine manufacturing

Professor Helen Rees recognised for outstanding contribution to global health

Overcoming barriers to African vaccine manufacturing

What’s the latest on global access to medicines?

The role of forecasting in market shaping: Hema Srinivasan on Forecasting Impact podcast

MedAccess joins G7 DFIs initiative to prepare for future pandemics

Combatting antimicrobial resistance with stewardship

MedAccess welcomes Cyrus Ardalan to its Board of Directors

UK improves access to life-saving malaria drugs

Do you speak market shaping? Reflections from the first Global Health Market Shaping conference

Alison Evans and Anil Soni join MedAccess Board

Keeping impact at the heart of MedAccess’ investment decisions

How do advance market commitments and volume guarantees shape healthcare markets?

Antony Ross OBE appointed Chair of MedAccess Investment Committee

MedAccess becomes founding partner of G7 initiative for impact investing in health

Non-communicable diseases: Tailoring our approach to innovative finance

MedAccess guarantees help medical innovations reach 530 million people in five years

Building better boardrooms with Violet Mordichai and TheBoardroom Africa

Five key lessons from our first five years

Professor Helen Rees appointed MedAccess Board Chair

MedAccess expects to deploy more than $150 million to support Global Fund’s fight against HIV, TB and malaria

2021 Annual Review: Accelerating impact and preparing for the future

Violet Mordichai joins MedAccess on board apprenticeship programme

MedAccess welcomes Vicky Johnson as new Chief Financial Officer

Promising progress but more to do for adolescent girls’ health

MedAccess’ life-changing impact highlighted in first Annual Report

Hema Srinivasan appointed Chief Access Officer

Fresh support from CDC Group at Global Fund Replenishment

Our partners

Subscribe to our newsletter

The crucial role of diagnostics: Insights from Sickle Cell Disease 